APA (7th ed.) Citation

JS, R., AS, K., & BN, R. (2026). Out-of-Pocket Spending for Biologic Drugs After Biosimilar Competition for Medicare Patients. JAMA network open, 9(1), e2554235. https://doi.org/10.1001/jamanetworkopen.2025.54235

Chicago Style (17th ed.) Citation

JS, Riegler, Kesselheim AS, and Rome BN. "Out-of-Pocket Spending for Biologic Drugs After Biosimilar Competition for Medicare Patients." JAMA Network Open 9, no. 1 (2026): e2554235. https://doi.org/10.1001/jamanetworkopen.2025.54235.

MLA (9th ed.) Citation

JS, Riegler, et al. "Out-of-Pocket Spending for Biologic Drugs After Biosimilar Competition for Medicare Patients." JAMA Network Open, vol. 9, no. 1, 2026, p. e2554235, https://doi.org/10.1001/jamanetworkopen.2025.54235.